Factor IX polypeptides and methods of use thereof | Patent Number 09623091

US 09623091 B2
Application Number15043455
Publication NumberUS 20160166657 A1
Pendency1 year, 2 months, 6 days
Filled DateFeb 12, 2016
Priority DateJul 9, 2010
Publication DateJun 16, 2016
Expiration DateJul 8, 2030
Inventor/ApplicantsHaiyan Jiang
Robert T. Peters
Samantha Truex
Glenn Pierce
ExaminesSZPERKA, MICHAEL EDWARD
Art Unit1644
Technology Center1600
Assignments
Bioverativ Therapeutics Inc.
Current
Biogen Hemophilia Inc.Bioverativ Therapeutics Inc.Sanofi
Original
Biogen
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.